NOTICE OF MAKE WHOLE REDEMPTION PRICE
Globenewswire· 2025-10-22 13:00
MAXIMA GRUPE, UAB(the "Issuer")1 €240,000,000 6.250 per cent. Notes due 2027(the "Notes") (ISIN: XS2485155464) (Common Code: 248515546) 22 October 2025 We refer to the terms and conditions of the Notes (the "Conditions") and the notice (the "Initial Notice") of the Issuer dated 10 October 2025 relating to the early redemption of the Notes on 27 October 2025 (the "Make Whole Optional Redemption Date") at the Make Whole Redemption Price together with interest accrued to, but excluding, and unpaid to the Make ...
Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats.
Globenewswire· 2025-10-22 13:00
Nordicus Partners Corporation Clinical outcomes in each visit: (1) Baseline; (2) post-induction; (3) post-treatment BEVERLY HILLS, California, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and U.S. life sciences companies in establishing themselves in the U.S. market, today announced the second positive efficacy dog and rat results (in ...
Great American Cookies and Marble Slab Creamery Build on Global Growth with Development Deal in Iraq
Globenewswire· 2025-10-22 13:00
U.S. Military Veteran to Open 10 Stores in Country over Next Five Years LOS ANGELES, Oct. 22, 2025 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc., parent company of Great American Cookies, Marble Slab Creamery, and 16 other restaurant concepts, has announced a new development deal to open 10 co-branded Great American Cookies and Marble Slab Creamery stores across Iraq over the next five years in partnership with Eric Wilson, a 27-year U.S. military veteran who served in Iraq. “FAT Brands con ...
SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum
Globenewswire· 2025-10-22 13:00
Company to conduct 1x1 meetings with investors on Wednesday, November 12thNEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Dr. Angelos Stergiou, President and Chief Executive Officer of SELLAS, will participate in the J.P. Morgan U.S. Opportunities Forum, which is being held on Wedne ...
Texxon Holding Limited Announces Pricing of $9.5 Million Initial Public Offering
Globenewswire· 2025-10-22 13:00
Shanghai, China, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Texxon Holding Limited (the “Company” or “Texxon”), a leading provider of supply chain management services in the plastics and chemical industries in East China, today announced the pricing of its initial public offering (the “Offering”) of 1,900,000 ordinary shares at a public offering price of US$5.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on October 22, 2025 ...
Primech AI Showcases HYTRON at Aramark Facilities Innovation Forum, Accelerating U.S. Expansion
Globenewswire· 2025-10-22 13:00
SINGAPORE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Primech Holdings Ltd. (Nasdaq: PMEC) (“Primech” or the “Company”), a leader in AI-powered hygienic robotics, announced its participation in the Aramark Facilities Innovation Forum in Warren, Michigan. Primech was invited to join a select group of companies presenting technologies chosen for their ability to drive measurable improvements in facility operations. The forum convened Aramark’s senior executives, operational leaders, and decision-makers from across mul ...
Draganfly Bolsters Military and Defense Capabilities with the Appointment of Veterans Victor Meyer and Keith Kimmel to its Military Board
Globenewswire· 2025-10-22 13:00
Tampa, FL, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced the appointment of Victor Meyer and Keith Kimmel as Senior Members of its Military Board of Advisors. Draganfly’s Military Board of Advisors is established to accelerate the Company’s defense strategy and ensure its technologies continue to deliver world-class innovation, reliability, and mis ...
Kodiak to Report Third Quarter 2025 Results on November 12, 2025
Globenewswire· 2025-10-22 13:00
MOUNTAIN VIEW, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Kodiak AI, Inc. (Nasdaq: KDK), a leading provider of AI-powered autonomous vehicle technology, today announced that it will release its third quarter 2025 results after the market closes on Wednesday, November 12, 2025. Management will host a conference call to discuss the results the same day at 5:00 PM ET (2:00 PM PT). To join the conference call please click on the call link here and complete the registration form. The call may also be accessed thr ...
Leading the AI-Native FMCG Revolution: Justin Floyd to Present RedCloud's Mission at Major Wall Street Investor Events
Globenewswire· 2025-10-22 12:55
LONDON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) ("RedCloud" or the "Company") the technology company behind the RedAI trading platform for businesses across Fast Moving Consumer Goods (“FMCG”) supply chains, today announced that CEO Justin Floyd will participate in two prominent U.S. investor conferences in November, as RedCloud continues to advance its mission to solve the$2Tn Global Inventory Gap1 in Fast Moving Consumer Goods ("FMCG"). Following recent strategic announcement ...
Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET
Globenewswire· 2025-10-22 12:54
CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its third quarter 2025 financial results will be released on Wednesday, October 29, 2025, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and p ...